Abstract
References
1.The European Malignant Hyperpyrexia Group. A protocol for investigation of malignant hyperpyrexia (MH) susceptibility . Br J Anaesth 1984 ; 56 : 1267 –1269 .
2.
Mulrooney L.
Counselling on malignant hyperpyrexia . Anaesthesia 1988 ; 43 : 727 –728 .
3.
Schulte-Sasse U.
,
Hell W.
,
Eberlein H.J.
Postoperative malignant hyperthermia and dantrolene therapy . Can Anaesth Soc J 1983 ; 30 : 635 –640 .
4.
Beebe J.
,
Sessler D.I.
Preparation of anaesthesia machines for patients susceptible to malignant hyperthermia . Anesthesiology 1988 ; 69 : 395 –400 .
5.
McKenzie A.
,
Pollock N.
Preparation of theatres for malignant hyperpyrexia patients . Anaesth Intens Care 1989 ; 17 : 510 –511 .
6.
Douglas K.J.
,
McMorland G.H.
The anaesthetic management of malignant hyperthermia susceptible parturient . Can Anaesth Soc J 1986 ; 33 : 371 –378 .
7.
Flewellen E.H.
,
Nelson T.E.
,
Jones W.P.
,
Arens J.F.
,
Wagner D.L.
Dantrolene dose response in awake man: Implications for management of malignant hyperthermia . Anesthesiology 1983 ; 59 : 275 –280 .
8.
Thomas D.W.
,
Dev V.J.
,
Whitehead M.J.
Malignant hyperpyrexia and isoflurane . Br J Anaesth 1987 ; 59 : 1196 –1198 .
9.
Heffron J.J.A.
Malignant hyperthermia: Biochemical aspects of the acute episode . Br J Anaesth 1988 ; 60 : 274 –278 .
10.
Pollock N.
,
Blair G.
Reconstitution of dantrolene . Anaesth Intens Care 1989 ; 17 : 383 .